About HeartFlow
HeartFlow is a company based in Redwood City (United States) founded in 2007. HeartFlow has raised $936.05 million across 12 funding rounds from investors including Fidelity Investments, Hayfin and HHS. HeartFlow offers products and services including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis. HeartFlow operates in a competitive market with competitors including Change Healthcare, AIdoc, Cleerly, Median and AI Medical Service, among others.
- Headquarter Redwood City, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Heartflow, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$936.05 M (USD)
in 12 rounds
-
Latest Funding Round
$98.36 M (USD), Series F
Mar 27, 2025
-
Investors
Fidelity Investments
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HeartFlow
HeartFlow is a publicly listed company on the NASDAQ with ticker symbol HTFL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HeartFlow
HeartFlow offers a comprehensive portfolio of products and services, including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis.
Efficiently detects coronary artery disease from CCTA scans.
Assesses blood flow in coronary arteries for treatment decisions.
Quantifies and characterizes plaque to inform disease risk management.
People of HeartFlow
Unlock access to complete
Unlock access to complete
Funding Insights of HeartFlow
HeartFlow has successfully raised a total of $936.05M across 12 strategic funding rounds. The most recent funding activity was a Series F round of $98.36 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HeartFlow
HeartFlow has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Hayfin and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Locked | Locked | Locked | |
|
Private debt investments are directed across multiple sectors.
|
Locked | Locked | Locked |
Investor details for HeartFlow
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HeartFlow
Investment portfolio details for HeartFlow
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HeartFlow
Detailed financials for HeartFlow
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Heartflow Comparisons
Peer comparison for HeartFlow
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HeartFlow
HeartFlow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, Cleerly, Median and AI Medical Service, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| Locked | Locked | Locked |
Medical imaging software and services are provided for clinical trials.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
Detailed competitors of HeartFlow
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Heartflow
Complete news archive for HeartFlow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeartFlow
HeartFlow was founded in 2007 and raised its 1st funding round 2 years after it was founded.
HeartFlow is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
John Farquhar is the current CEO of HeartFlow.
HeartFlow is a funded company, having raised a total of $936.05M across 12 funding rounds to date.
HeartFlow was founded in 2007 and is based in Redwood City, United States. Operations focus on the cardiovascular sector, where CT scans and high-performance computing are utilized to analyze blood flow in coronary arteries. Data is supplied to physicians for diagnostic purposes, with studies indicating enhanced accuracy over standard CT scans alone. Services support clinical decision-making in heart disease assessment.
HeartFlow's top competitors include Change Healthcare, AIdoc and eCential Robotics.
HeartFlow offers Roadmap Analysis, FFR CT Analysis, and Plaque Analysis.
Yes, HeartFlow is publicly traded on NASDAQ under the ticker symbol HTFL.
HeartFlow has 12 investors. Key investors include Fidelity Investments, Hayfin, HHS, Baillie Gifford, and Janus Henderson Investors.
The ticker symbol of HeartFlow is HTFL on NASDAQ.
The valuation of HeartFlow is $1.3B as of Jun 2019.